Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention

By Ahn Sung Gyun   Lee Seung-Hwan   Sung Joong Kyung   Kim Jang-Young   Yoon Junghan  

Platelets, Vol. 22, Iss. 4, 2011-06 ,pp. : 305-307

Informa Healthcare

Access to resources Recommend Favorite

Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease

By Paulu Petra  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 1-6

Springer Publishing Company

Access to resources Recommend Favorite

Long‐term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea

By  

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1297-1302

John Wiley & Sons Inc

Access to resources Recommend Favorite

PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy

By Smith S. M. G.   Judge H. M.   Peters G.   Armstrong M.   Dupont A.   Gaussem P.   Storey R. F.  

Platelets, Vol. 16, Iss. 6, 2005-09 ,pp. : 340-345

Informa Healthcare

Access to resources Recommend Favorite

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

By Andersen K.   Hurlen M.   Arnesen H.   Seljeflot I.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite